Award from the Maryland Industrial Partnerships (MIPS) program supports work to formulate Clofazimine for treatment of recurrent C. difficile infections.

New center established by the School of Pharmacy, in collaboration with the University of Michigan, will increase access to safe and effective generic drugs through collaborative research, training, and exchange.

Virtual event brings together more than 500 attendees, including stakeholders from the FDA, academia, and industry.

Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation brings together more than 600 researchers from academia, government, and industry.

More than 100 researchers from academia, government, and industry come together to share existing knowledge, new approaches, best practices, and continued challenges in pediatric drug formulation.

Dr. Maureen Kane’s leadership of the Mass Spectrometry Center make her a UMB Champion of Excellence.

A lifelong passion for research and desire to inspire the next generation of scientists make graduate student Alecia Dent a UMB Champion of Excellence.

Dr. Hongbing Wang receives $100,000 from the National Toxicology Program to help support his work to develop a new cell culture model for use in high-throughput screening assays.

Event spotlights cutting-edge pharmaceutical sciences research being conducted across the region and offers networking opportunities for attendees.

Partnership will facilitate the development of therapeutics for pediatric patients and provide research and education opportunities for faculty, students, and trainees.

Research published by Hongbing Wang, PhD, professor in the Department of Pharmaceutical Sciences (PSC), may explain how some liver cancer cells obtain the nutrition they need to proliferate.

More than 500 researchers from academia, government, and industry gather to gain perspective on biomarker development and the application of biomarkers in preclinical and clinical research.